Home LiteratureArticle Details
PMID: 7836924 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

T cell genetic background determines default T helper phenotype development in vitro.

The Journal of experimental medicine ·Vol. 181 ·No. 2 ·1995-02-01 ·Pages 713-21

Hsieh CS, Macatonia SE, O'Garra A, Murphy KM

Abstract

A host's ability to resist certain pathogens such as Leishmania major can depend upon the phenotype of T helper (Th) subset that develops. Different murine genetic backgrounds are known to significantly alter the direction of Th subset development, although the cellular basis of this influence is poorly understood. To examine the basis of this effect we used an in vitro alpha/beta-T cell receptor (TCR) transgenic system for analysis of Th phenotype development. To control for TCR usage, we derived the DO11.10 alpha/beta-TCR transgene in several genetic backgrounds. Our findings suggest that the effects of genetic background on Th phenotype development reside within the T cell, and not the antigen-presenting cell compartment. Transgenic T cells from both the B10.D2 and BALB/c backgrounds showed development toward either the Th1 or Th2 phenotype under the strong directing influence of interleukin (IL) 12 and IL4, respectively. However, when T cells were activated in vitro under neutral conditions in which exogenous cytokines were not added, B10.D2-derived T cells acquired a significantly stronger Th1 phenotype than T cells from the BALB/c background, correspondent with in vivo Th responses to Leishmania in these strains. Importantly, these cytokine differences resulted in distinct functional properties, because B10.D2- but not BALB/c-derived T cells could induce macrophage production of nitric oxide, an important antimicrobial factor. Thus, the genetically determined default Th phenotype development observed in vitro may correspond to in vivo Th subset responses for pathogens such as Leishmania which do not initiate strong Th phenotype-directing signals.

MeSH Terms
Animals Antibody-Producing Cells/immunology Cell Differentiation/genetics Cells, Cultured Leishmania major/immunology Macrophages/immunology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic Nitric Oxide/biosynthesis Phenotype Receptors, Antigen, T-Cell, alpha-beta/genetics Th1 Cells/immunology Th2 Cells/immunology
Chemicals
Receptors, Antigen, T-Cell, alpha-beta Nitric Oxide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Hsieh C S
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Macatonia S E
O'Garra A
Murphy K M
References (51)
51 references, click to expand
  1. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.
    J Immunol. 1980 Dec;125(6):2665-72 PMID: 6159417
  2. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.
    J Immunol. 1992 Apr 1;148(7):2142-7 PMID: 1532000
  3. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.
    J Exp Med. 1981 Mar 1;153(3):557-68 PMID: 6454739
  4. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
    Anal Biochem. 1982 Oct;126(1):131-8 PMID: 7181105
  5. The major histocompatibility complex-restricted antigen receptor on T cells. IV. An antiidiotypic antibody predicts both antigen and I-specificity.
    J Exp Med. 1983 Nov 1;158(5):1635-46 PMID: 6195288
  6. CD8 surface levels alter the fate of alpha/beta T cell receptor-expressing thymocytes in transgenic mice.
    J Exp Med. 1992 Apr 1;175(4):1013-25 PMID: 1532412
  7. Regulation of immunity to parasites by T cells and T cell-derived cytokines.
    Annu Rev Immunol. 1992;10:385-409 PMID: 1590992
  8. Identification and distribution of the costimulatory receptor CD28 in the mouse.
    J Immunol. 1992 Jul 15;149(2):380-8 PMID: 1320641
  9. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system.
    Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6065-9 PMID: 1385868
  10. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.
    Science. 1992 Jul 24;257(5069):539-42 PMID: 1636090
  11. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.
    Immunol Rev. 1992 Jun;127:183-204 PMID: 1354651
  12. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.
    J Exp Med. 1992 Oct 1;176(4):1091-8 PMID: 1328464
  13. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
    J Immunol. 1993 Feb 1;150(3):925-31 PMID: 8093707
  14. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
    J Exp Med. 1993 Apr 1;177(4):1199-204 PMID: 8096238
  15. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3725-9 PMID: 8097322
  16. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
    Science. 1993 Apr 23;260(5107):547-9 PMID: 8097338
  17. Recombinant interleukin 12 cures mice infected with Leishmania major.
    J Exp Med. 1993 May 1;177(5):1505-9 PMID: 8097524
  18. Pathogen-induced Th1 phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent.
    Int Immunol. 1993 Apr;5(4):371-82 PMID: 8494824
  19. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
    J Exp Med. 1993 Jun 1;177(6):1797-802 PMID: 8098733
  20. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
    J Exp Med. 1993 Aug 1;178(2):567-77 PMID: 8101861
  21. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10188-92 PMID: 7901851
  22. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent.
    Int Immunol. 1993 Sep;5(9):1119-28 PMID: 7902129
  23. Cytokine-mediated regulation of chronic intestinal helminth infection.
    J Exp Med. 1994 Jan 1;179(1):347-51 PMID: 8270879
  24. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
    J Exp Med. 1994 Feb 1;179(2):447-56 PMID: 7905017
  25. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
    J Exp Med. 1994 Jul 1;180(1):211-22 PMID: 7516408
  26. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
    J Exp Med. 1994 Jul 1;180(1):223-31 PMID: 7516409
  27. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity.
    Immunity. 1994 Apr;1(1):73-83 PMID: 7889402
  28. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
    J Immunogenet. 1983 Oct;10(5):395-412 PMID: 6606002
  29. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.
    Nature. 1985 May 23-29;315(6017):333-6 PMID: 2582266
  30. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    J Immunol. 1985 Sep;135(3):2108-14 PMID: 3926895
  31. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
    J Immunol. 1986 Apr 1;136(7):2348-57 PMID: 2419430
  32. Immunological regulation and control of experimental leishmaniasis.
    Int Rev Exp Pathol. 1986;28:79-116 PMID: 3516912
  33. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.
    J Exp Med. 1988 Nov 1;168(5):1675-84 PMID: 2903212
  34. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
    J Exp Med. 1989 Jan 1;169(1):59-72 PMID: 2521244
  35. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.
    Annu Rev Immunol. 1989;7:145-73 PMID: 2523712
  36. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    J Immunol. 1989 Jul 1;143(1):266-74 PMID: 2499629
  37. A functional dichotomy in CD4+ T lymphocytes.
    Immunol Today. 1988 Sep;9(9):268-74 PMID: 2908229
  38. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.
    J Immunol. 1990 Jan 1;144(1):278-83 PMID: 2104889
  39. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
    J Exp Med. 1990 Jan 1;171(1):115-27 PMID: 2104918
  40. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.
    J Immunol. 1990 Jun 15;144(12):4794-7 PMID: 2351828
  41. Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding.
    Proc Natl Acad Sci U S A. 1990 Aug;87(16):6186-90 PMID: 2117275
  42. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.
    J Exp Med. 1990 Sep 1;172(3):921-9 PMID: 2117636
  43. IL-4 directs the development of Th2-like helper effectors.
    J Immunol. 1990 Dec 1;145(11):3796-806 PMID: 2147202
  44. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.
    Science. 1990 Dec 21;250(4988):1720-3 PMID: 2125367
  45. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli.
    Infect Immun. 1991 May;59(5):1709-15 PMID: 1902195
  46. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function.
    Immunol Today. 1991 Mar;12(3):A58-61 PMID: 1829891
  47. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype.
    J Immunol. 1991 Nov 1;147(9):2991-3000 PMID: 1680924
  48. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    J Immunol. 1991 Nov 1;147(9):3149-55 PMID: 1833466
  49. The role of T-cell subsets and cytokines in the regulation of infection.
    Immunol Today. 1991 Oct;12(10):346-8 PMID: 1683536
  50. IL-4 induces a Th2 response in Leishmania major-infected mice.
    J Immunol. 1992 Feb 15;148(4):1182-7 PMID: 1531351
  51. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice.
    Parasite Immunol. 1980 Winter;2(4):303-14 PMID: 7220075
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1995-02-01
Pages
713-21
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2191880
Subset
IM
Grants
NIAID NIH HHS · 1 PO1 AI31238-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]